Pacira Biosciences Inc (NASDAQ:PCRX)
| 60.65 Delayed Data As of May 24 |  -2.46 / -3.90%Today’s Change | 45.05 Today|||52-Week Range 82.16 | +0.80% Year-to-Date |
Latest PCRX News | Press Releases
No recent news for Pacira Biosciences Inc.
Today’s Trading
| Previous close | 63.11 |
| Today’s open | 64.18 |
| Day’s range | 60.05 - 64.55 |
| Volume | 21,318 |
| Average volume (3 months) | 544,998 |
| Market cap | $2.9B |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | -72.19% |
| Earnings growth (this year) | +16.85% |
| Earnings growth (next 5 years) | +26.70% |
| Revenue growth (last year) | +26.04% |
| P/E ratio | 72.2 |
| Price/Sales | 5.07 |
| Price/Book | 3.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PBHPrestige Consumer He... | -0.50 | -0.89% |
| ACADACADIA Pharmaceutica... | -0.82 | -4.88% |
| KRTXKaruna Therapeutics ... | -2.21 | -2.05% |
| ---- |
Data as of 4:00pm ET, 05/24/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | $0.85 |
| Annual revenue (last year) | $541.5M |
| Annual profit (last year) | $42.0M |
| Net profit margin | 7.75% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tampa, Florida |
Forecasts
